- Business Wire•3 hours agoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Taro Pharmaceutical Industries Ltd. Investors and Encourages Investors to Contact the Firm
Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors who purchased Taro Pharmaceutical Industries Ltd. securities between July 3, 2014 and September 9, 2016, inclusive .
- Business Wire•yesterdayTARO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Taro Pharmaceutical Industries Ltd. and a Lead Plaintiff Deadline of December 27, 2016
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Taro Pharmaceutical Industries Ltd.
- Accesswire•yesterdayKessler Topaz Meltzer & Check, LLP Reminds Taro Pharmaceutical Industries Ltd. Shareholders of Important Deadline in Class Action Lawsuit
RADNOR, PA / ACCESSWIRE / December 7, 2016 / The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action lawsuit has been filed in the United States District Court for ...
TARO : Summary for Taro Pharmaceutical Industries - Yahoo Finance
Taro Pharmaceutical Industries Ltd. (TARO)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||104.62 x 100|
|Ask||104.95 x 200|
|Day's Range||103.58 - 105.10|
|52 Week Range||92.28 - 157.99|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||8.27|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|